Morphometric changes in growth of the rat pelvis after papain administration
β Scribed by Dixon, Andrew D. ;Gakunga, Peter T.
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 709 KB
- Volume
- 235
- Category
- Article
- ISSN
- 0003-276X
No coin nor oath required. For personal study only.
β¦ Synopsis
The proteolytic enzyme, papain, was given systematically to evaluate the short-and long-term effects of inhibition of endochondral bone formation on pelvic growth, with emphasis on the innominate bone. Ninety-eight Lewis-strain male rats, used concurrently for craniofacial growth studies, were divided into two groups. Thirty rats from Group I (n = 48) received 2% crude papain i.p. daily from 25-40 days-of-age and were euthanized at 40, 54, and 70 days-of-age. Thirty-five rats from Group I1 (n=50) were given papain at the same dose from 25-70 days-of-age and were euthanized at 26, 40, 54, 70, and 120 days. The remaining animals in both groups were the controls. Standardized dorsoventral pelvic radiographs were taken of all 98 animals. Ten linear dimensions were measured on each and the data evaluated statistically. A reduction both in size and rate of growth of the bony pelvis was found. All the anteroposterior and most of the transverse pelvic dimensions were significantly shorter, to a greater extent in the prolonged papain group. Bi-ischial width was increased, perhaps to compensate for pelvic shortening and to accommodate the pelvic contents. The findings may contribute to our better understanding of abnormal endochondral bone growth in the pelvis.
π SIMILAR VOLUMES
## Abstract The pharmacokinetics of desethylamiodarone (DEA), the active metabolite of amiodarone (AM), were studied in the rat after administration of AM or preformed metabolite. Rats received 10βmg/kg of either intravenous or oral AM HCl or DEA base. Blood samples were obtained via a surgically i
## Abstract ## Purpose To demonstrate in the rat 9L cerebral tumor model that repeated MRI measurements can quantitate acute changes in the bloodβbrain distribution of Gadomer after dexamethasone administration. ## Materials and Methods A total of 16 Fischer 344 rats were studied at 7T, 15 days
The pharmacokinetics of the anticholinergic drug ethopropazine (ET) have been studied in the rat after intravenous (i.v.) and oral administration. After i.v. doses of 5 and 10 mg/kg ET HCl, mean +/- S.D. plasma AUC were 9836 +/- 2129 (n = 4 rats) and 13096 +/- 4186 ng h/mL (n = 5 rats), respectively
The distribution, metabolism, and pharmacokinetics of physostigmine (Phy) and the time course of butyrylcholinesterase (BuChE) in plasma and cholinesterase (ChE) activity in brain and muscle and their relationship to Phy concentration were described after oral administration of 3H-Phy (650pg kg-') t